Lung Cancer (NSCLC) [Plasma]

Applicable for all labs undertaking molecular testing of cfDNA in plasma for EGFR and KRAS gene variants in NSCLC.

Lung cancer (NSCLC) [Tissue]

Applicable to all labs undertaking molecular testing for this cancer type using FFPE tissue.
It is MANDATORY to participate in this EQA scheme for the COMMON BIOMARKERS option, you must also select an item from the Lung New and Emerging biomarkers options. if you do not want to participate select “I do not wish to purchase Lung New and Emerging”